All | Anemia | No anemia | p value | |
---|---|---|---|---|
Demographic data | ||||
Number | 175 | 64 | 111 | |
Age, years | 67 ± 11 | 71 ± 10 | 65 ± 11 | <0.01 |
Males, number (%) | 134 (76.6) | 50 (78.1) | 84 (75.7) | 0.71 |
Body mass index, kg/m2 | 24.2 ± 3.9 | 23.7 ± 4.5 | 24.6 ± 3.5 | 0.02 |
Systolic blood pressure, mmHg | 135 ± 18 | 137 ± 20 | 135 ± 17 | 0.59 |
Diastolic blood pressure, mmHg | 75 ± 13 | 72 ± 14 | 76 ± 13 | 0.01 |
Pulse pressure, mmHg | 61 ± 15 | 64 ± 17 | 59 ± 14 | 0.02 |
Heart rate, bpm | 67 ± 11 | 67 ± 10 | 67 ± 12 | 0.98 |
Resistive index | 0.70 ± 0.09 | 0.74 ± 0.09 | 0.67 ± 0.08 | <0.01 |
Left ventricular ejection fraction | 0.63 ± 0.12 | 0.63 ± 0.14 | 0.64 ± 0.11 | 0.92 |
Laboratory data | ||||
Hemoglobin, g/dl | 13.1 ± 1.7 | 11.4 ± 1.0 | 14.1 ± 1.2 | <0.01 |
Estimated GFR, ml/min./1.73 m2 | 57.7 ± 23.1 | 48.3 ± 24.8 | 63.1 ± 20.3 | <0.01 |
Qualitative urine protein, number (%) | 51 (29.3) | 31 (49.2) | 20 (18.0) | <0.01 |
Hemoglobin A1c, % | 6.4 ± 1.7 | 6.6 ± 2.1 | 6.4 ± 1.4 | 0.98 |
Comorbidities, number (%) | ||||
Diabetes mellitus | 91 (52.0) | 35 (54.7) | 56 (50.5) | 0.60 |
Dyslipidemia | 122 (69.7) | 46 (71.9) | 76 (68.5) | 0.64 |
Coronary artery disease | 104 (59.4) | 41 (64.1) | 63 (56.8) | 0.34 |
Peripheral artery disease | 34 (19.4) | 16 (25.0) | 18 (16.2) | 0.16 |
History of congestive heart failure | 12 (6.8) | 6 (9.4) | 6 (5.4) | 0.35 |
History of cerebral infarction | 26 (14.9) | 12 (18.8) | 14 (12.6) | 0.30 |
Current smoking | 53 (30.6) | 19 (30.2) | 34 (30.9) | 0.92 |
COPD | 8 (4.6) | 4 (3.6) | 4 (6.3) | 0.41 |
Medications, number (%) | ||||
RAAS inhibitors | 125 (71.4) | 52 (81.3) | 73 (65.8) | 0.02 |
Calcium channel blockers | 114 (65.1) | 47 (73.4) | 67 (60.4) | 0.07 |
Beta blockers | 57 (32.6) | 17 (26.6) | 40 (36.0) | 0.20 |
Statins | 92 (52.6) | 37 (57.8) | 55 (49.5) | 0.29 |